Press Releases

ClearNote Health Earns Approval for Avantect® Pancreatic Cancer Test from New York State Department of Health

ClearNote Health announced New York State has approved its Avantect Pancreatic Cancer Test. The ClearNote Health Laboratory now has its NYSDOH permit, as well as its CLIA certification and CAP accreditation.

Cleveland Clinic Announces the Rollout of Ambience Healthcare’s AI Platform

CluePoints named as Finalist in 2025 ACDM Awards

CluePoints, provider of leading statistical and AI-driven software solutions, has been shortlisted for “Team Excellence in the Management of Clinical Data” at the 2025 ACDM Awards.

Phastar Secures SCOPE US ‘Best in Show’ Accolade for Clinical Intelligence Platform

Phastar, a global specialist biometrics & data science contract research organization (CRO), won a Best of Show Award at Summit for Clinical Ops Executives (SCOPE) US 2025.

Yourgene Health Launches IONA Care+ Non-invasive Prenatal Testing Service

Thermo Fisher Scientific’s New Spatial Imaging System Enables Researchers to Generate High-quality Data, Making it Easier to Enter the Field of Spatial Tissue Proteomics

Today, Thermo Fisher Scientific launched the Invitrogen™ EVOS™ S1000 Spatial Imaging System to offer scientists new capabilities to understand the organization of cells within tissues.

Baylor Genetics Marks a Decade of Leadership in Precision Diagnostics, Empowering Patients, Healthcare Providers and Partners with Trusted Genetic Insights

Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, marks its 10-year anniversary this month, a milestone that demonstrates the company’s long-term commitment to unlock the power of precision diagnostics, transform healthcare, and end the diagnostic odyssey for patients with the most complex genetic disorders.

Baylor Genetics Chief Medical Officer Christine Eng, M.D., Shares New RNA Sequencing Insights for Rare Disease at Precision Medicine World Conference 2025

Christine Eng, M.D., chief medical officer and chief quality officer at Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, will present on new RNA sequencing insights for rare disease as part of the Clinical Dx (Diagnostic) Showcase track at the Precision Medicine World Conference (PMWC) 2025.

Owkin Announces First Patient Dosed in Phase I AI-optimized Clinical Trial of OKN4395, a First-in-Class EP2/EP4/DP1 Triple Inhibitor for Patients with Solid Tumors

Ambience Healthcare Joins athenahealth’s Marketplace Program to Support Clinicians with AI-assisted Documentation, Point of Care CDI & Coding, and Care Coordination

OGT delivers superior MRD detection capabilities with new SureSeq Myeloid MRD Panel

Ultra-low variant detection (including very large FLT3-ITDs) by OGT's new SureSeq™ Myeloid MRD Panel enables a stronger characterization of a sample’s current AML status

Pharmapack Europe the ‘Heart of Pharma’ Start-ups in Paris

At Pharmapack Europe 2025, six exceptional start-ups have been honoured with the prestigious ‘Heart of Pharma’ awards, recognising their groundbreaking contributions to drug delivery, packaging, and patient care. Selected from a competitive field of 26 innovators, these companies are transforming healthcare with technologies that promise to revolutionize industry standards. The winners include innovations such as sustainable biofuel-powered electronics, patient-friendly nasal sprays, next-generation intradermal drug delivery devices, and breakthrough vial-filling systems. Representing global excellence, recipients hail from the U.S., UK, Ireland, France, and the DACH region. With over 6,000 attendees and 370 exhibitors, Pharmapack remains the must-attend event for pharma innovation. Don’t miss the chance to cover these transformative start-ups and their award-winning technologies.

Pharmapack Europe Awards 2025 Winners

Pharmapack Europe 2025 proudly announces the winners of its newly reformatted Pharmapack Awards, recognising excellence across six transformative categories in pharmaceutical packaging and drug delivery. This year’s honourees include innovative advancements in sustainable materials, patient-centered design, and next-generation devices—all poised to redefine healthcare delivery. Notable winners include SHL Medical’s Elexy™ reusable electromechanical autoinjector, Huhtamaki’s Omnilock™ Ultra PAPER for eco-friendly packaging, and Mitsubishi Gas Chemical’s OXYCAPT multilayer vial for gene therapy. The prestigious Woman of the Year Award celebrates Asmita Khanolkar of SMC Ltd. for her decades-long contributions to drug-device innovation.

Glox Therapeutics Awarded Share of £3M Collaborative Discovery Programme Funding from Cystic Fibrosis Antimicrobial Resistance Syndicate

* £500K grant to advance discovery and development of effective precision antibiotics targeting antimicrobial-resistant lung infections in people with cystic fibrosis * Programme delivered by CF AMR Syndicate offers cross-sector collaboration and support to address urgent unmet need

ELRIG Announces Drs Jue Wang and Robert Grundy as Keynote Speakers at Research & Innovation 2025

Medix Biochemica Expands its Offering of Critical IVD Raw Materials to Premium Blockers and Stabilizers by Acquiring CANDOR Bioscience

Medix Biochemica has announced the acquisition of CANDOR Bioscience GmbH, which strengthens Medix Biochemica’s portfolio in critical raw materials for IVD and enhances its capability to support immunoassay developers across the world.

Ambience Healthcare and St. Luke's Health System Partner to Reduce Clinician Burnout and Increase Patient Face Time

Ambience Healthcare, the leading AI platform for healthcare documentation, scribing, coding, CDI, and patient summaries, announced today a pilot study with St. Luke's Health System has resulted in a 25% reduction in clinician burnout and a nearly 23% increase in patient face time for clinicians.

Proscia’s Growth More Than Doubles As Customers Adopt Enterprise Pathology

Record year comes as the rise of precision medicine drives a surge in demand

Baylor Genetics to Integrate with Epic Aura to Enhance Efficiency and Deliver Genetic Testing Results to Hospitals and Health Systems

Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, today announced its integration with Aura, the specialty diagnostics suite from leading electronic health record (EHR) company Epic. This integration will give organizations using Epic the ability to order Baylor Genetics’ tests and view results directly in the EHR—supporting fast, informed treatment decisions and improving the provider experience. Baylor Genetics will be the first lab to offer WGS testing through Aura.

Absci and Owkin Synergize Leading TechBio Platforms to Advance Generative AI Drug Discovery

Collaboration combines Owkin’s novel AI target discovery and agentic AI expertise with Absci’s leading AI de novo design models to accelerate the discovery and design of potential first-in-class therapeutics